PEDIATRICS Vol. 70 No. 1 July 1982, pp. 99-105
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacArthur, B. A.
Right arrow Articles by Elkins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacArthur, B. A.
Right arrow Articles by Elkins, J.

School Progress and Cognitive Development of 6-Year-Old Children Whose Mothers Were Treated Antenatally with Betamethasone

B. A. MacArthur MA, PhD1, R. N. Howie MB, ChB, FRACP1, J. A. Dezoete BA, NZRGON, NZRM1, and J. Elkins BSc, BEd, PhD1

1 Departments of Education and Paediatrics, University of Auckland, Auckland, New Zealand, and Schonell Educational Research Centre, University of Queensland, Brisbane, Australia

The cognitive development of children whose mothers had been included in the first Auckland trials of betamethasone therapy in premature labor were studied. An earlier study of these children used psychometric tests during the fifth year of life. In the present study tests were given during the seventh year of life (the second year of school) to 250 (82.2%) of 304 surviving children. Of the 250 children, 139 were in the group whose mothers had received betamethasone and 111 were in the control group. Further tests of cognitive development were made, together with assessment of the children's progress in school. Again, on the majority of measures there were no significant differences between children whose mothers had received betamethasone and the children in the control group. Calculations of statistical power showed that important differences were unlikely to have been missed.

Submitted on August 31, 1981
Accepted on January 11, 1982




This article has been cited by other articles:


Home page
 PediatricsHome page
B. H. Lee, B. J. Stoll, S. A. McDonald, R. D. Higgins, and for the National Institute of Child Health and Hum
Neurodevelopmental Outcomes of Extremely Low Birth Weight Infants Exposed Prenatally to Dexamethasone Versus Betamethasone
Pediatrics, February 1, 2008; 121(2): 289 - 296.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
S. R Dalziel, V. K Lim, A. Lambert, D. McCarthy, V. Parag, A. Rodgers, and J. E Harding
Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial
BMJ, September 24, 2005; 331(7518): 665.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
P. Kumar, R. Seshadri, and W. A. Grobman
Neurodevelopmental Outcome of Very Low Birth Weight Infants After Multiple Courses of Antenatal Corticosteroids
Reproductive Sciences, October 1, 2004; 11(7): 483 - 487.
[Abstract] [PDF]

Home page
 PediatricsHome page
S. R. Dalziel, A. Liang, V. Parag, A. Rodgers, and J. E. Harding
Blood Pressure at 6 Years of Age After Prenatal Exposure to Betamethasone: Follow-up Results of a Randomized, Controlled Trial
Pediatrics, September 1, 2004; 114(3): e373 - e377.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
A. G. S. Philip and G. C. Liggins
Historical Perspectives: The Underpinnings of Neonatal/Perinatal Medicine: Antepartum Glucocorticoid Treatment
NeoReviews, November 1, 2002; 3(11): e227 - 228.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
R Agarwal, M L Chiswick, S Rimmer, G M Taylor, R J Q McNally, R D Alston, and S W D'Souza
Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2002; 86(2): F96 - F101.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. A. Guinn, M. W. Atkinson, L. Sullivan, M. Lee, S. MacGregor, B. V. Parilla, J. Davies, K. Hanlon-Lundberg, L. Simpson, J. Stone, et al.
Single vs Weekly Courses of Antenatal Corticosteroids for Women at Risk of Preterm Delivery: A Randomized Controlled Trial
JAMA, October 3, 2001; 286(13): 1581 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. E. McGowan, G. Sysyn, K. H. Petersson, G. B. Sadowska, O. P. Mishra, M. Delivoria-Papadopoulos, and B. S. Stonestreet
Effect of Dexamethasone Treatment on Maturational Changes in the NMDA Receptor in Sheep Brain
J. Neurosci., October 1, 2000; 20(19): 7424 - 7429.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A. Whitelaw and M. Thoresen
Antenatal steroids and the developing brain
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2000; 83(2): 154F - 157.
[Abstract] [Full Text]

Home page
 PediatricsHome page
L. W. Doyle, G. W. Ford, A. L. Rickards, E. A. Kelly, N. M. Davis, C. Callanan, and A. Olinsky
Antenatal Corticosteroids and Outcome at 14 Years of Age in Children With Birth Weight Less Than 1501 Grams
Pediatrics, July 1, 2000; 106(1): 2e - 2.
[Abstract] [Full Text]

Home page
 PediatricsHome page
A. B. Dessens, H. S.-d. Haas, and J. G. Koppe
Twenty-Year Follow-Up of Antenatal Corticosteroid Treatment
Pediatrics, June 1, 2000; 105(6): 77e - 77.
[Abstract] [Full Text]

Home page
 Obstet GynecolHome page
W. L. HUANG, L. D. BEAZLEY, J. A. QUINLIVAN, S. F. EVANS, J. P. NEWNHAM, and S. A. DUNLOP
Effect of Corticosteroids on Brain Growth in Fetal Sheep
Obstet. Gynecol., August 1, 1999; 94(2): 213 - 218.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. E. Avery
A Controlled Trial of Antepartum Glucocorticoid Treatment for Prevention of the Respiratory Distress Syndrome in Premature Infants, by G. C. Liggins, MB, PhD, FRCOG, and R. N. Howie, MB, MRACP, Pediatrics, 1972;50:515-525
Pediatrics, July 1, 1998; 102(1): 250 - 252.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
J. Vyas and S. Kotecha
Effects of antenatal and postnatal corticosteroids on the preterm lung
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 147F - 150.
[Full Text]

Home page
 PediatricsHome page
C. A. Crowther, J. E. Hiller, R. R. Haslam, J. S. Robinson, and the ACTOBAT Study Group
Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: Adverse Effects at 12-Month Follow-up
Pediatrics, March 1, 1997; 99(3): 311 - 317.
[Abstract] [Full Text] [PDF]